The Discounted Cash Flow (DCF) valuation of Corcept Therapeutics Inc (CORT) is 41.13 USD. With the latest stock price at 35.60 USD, the upside of Corcept Therapeutics Inc based on DCF is 15.5%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 7.3% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 28.21 - 83.55 | 41.13 |
| Upside | -20.8% - 134.7% | 15.5% |